BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  Business

  Cardurion Raises $260M to Advance Cardiovascular Assets

  Backed by Bain Capital, Cardurion Pharmaceuticals will use the Series B funds to advance two assets for heart failure and other cardiovascular conditions.

  July 16, 2024

   · 

  1 min read

   · 

  Tyler Patchen
• 

  Legal

  Vertex Sues US Government Over Fertility Services for Casgevy Treatment

  Vertex has filed a complaint against the Department of Health and Human Services, seeking to make its fertility preservation program available to federally insured patients needing Casgevy treatment.

  July 16, 2024

   · 

  1 min read

   · 

  Tristan Manalac
• 

  Weight loss

  Will Eli Lilly Overtake Novo Nordisk in Weight-Loss Drug Race?  

  Some analysts say so, and a recent study suggested Lilly’s tirzepatide beat Novo’s semaglutide at inducing weight loss, but there are other factors in the market race. 

  July 16, 2024

   · 

  4 min read

   · 

  Tyler Patchen
• 

  Government

  Democratic Senators to Meet with Novo Nordisk After Withdrawal of Levemir: Reuters

  After discontinuing its long-acting insulin product Levemir, Novo has again found itself under legislative scrutiny, with three Democratic senators seeking a sit-down with the pharma.

  July 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cell therapy

  FDA Eyes Site Tours of Cell and Gene Therapy Manufacturers

  To improve its reviewers’ understanding of cell and gene therapy manufacturing, the agency has launched a program that will involve a tour of manufacturing facilities and daily workshops for its staffers.

  July 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Funding

  Novo Holdings Leads $100M Raise for Asceneuron’s Alzheimer’s Push

  Asceneuron, which develops small molecules targeting tau protein aggregation, plans to use the funds to advance its Alzheimer’s disease asset into Phase II.

  July 16, 2024

   · 

  1 min read

   · 

  Tyler Patchen
• 

  Career Advice

  Career Coach: Transition Into a Career in Biotech

  This week, Carina discusses how to transition into a career in biotech when you don’t have lab experience. Plus, handling difficult interviews and getting a “dry” promotion.

  July 16, 2024

   · 

  5 min read

   · 

  Carina Clingman
• 

  Manufacturing

  CordenPharma Expands GLP-1 Manufacturing Footprint in US and Europe with $980M Commitment

  To help keep pace with the demand for GLP-1 therapies, CordenPharma has announced a sizeable $980 million investment in its U.S. and European sites.

  July 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Press Releases

  Skin Neoplasms Market Estimated to Reach USD 3.8 Billion by 2034, Impelled by Widespread Adoption of Targeted Drugs

  July 16, 2024

   · 

  11 min read
• 

  Press Releases

  Type 1 Diabetes Market Estimated to Reach USD 9.4 Billion by 2034, Impelled by Increased Utilization of Artificial Pancreas Systems

  July 16, 2024

   · 

  12 min read